CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 124 enrolled
Drug / intervention
Racecadotril plus ORS +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03463512
NCT03463512Phase 3Completed
CompareCT.gov

Multicenter, Open-label, Controlled, Randomized Clinical Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea

Abbott·interventional·Posted Mar 13, 2018·Updated Oct 23, 2019

In Brief

A Phase 3 clinical trial evaluating Racecadotril plus ORS and ORS for Diarrhea. Completed, enrolled 124 participants across 1 site.

Detailed Summary

Multicenter, open-label, controlled, randomized clinical study to evaluate the efficacy and safety of Racecadotril in infants, children and adolescents with acute diarrhea

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiarrhea
CountriesRussia
Collaborators--

Timeline

Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedMar 13, 2018
Enrollment StartMar 29, 2018
Primary CompletionSep 10, 2018
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 8.3 years ago

Interventions

Racecadotril plus ORSdrug

Racecadotril plus ORS

ORSdrug

ORS